InvestorsObserver
×
News Home

Can Sorrento Therapeutics Inc (SRNE) Stock Rise to the Top of Healthcare Sector Friday?

Friday, January 14, 2022 02:49 PM | InvestorsObserver Analysts

Mentioned in this article

Can Sorrento Therapeutics Inc (SRNE) Stock Rise to the Top of Healthcare Sector Friday?

A rating of 60 puts Sorrento Therapeutics Inc (SRNE) near the top of the Healthcare sector according to InvestorsObserver. Sorrento Therapeutics Inc's score of 60 means that it ranks higher than 60% of stocks in the sector. In addition, its overall score of 36 ranks it higher than 36% of all stocks.

Overall Score - 36
SRNE has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on SRNE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 36 would rank higher than 36 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Sorrento Therapeutics Inc Stock Today?

Sorrento Therapeutics Inc (SRNE) stock is up 3.24% while the S&P 500 has fallen -0.48% as of 2:49 PM on Friday, Jan 14. SRNE has risen $0.14 from the previous closing price of $4.33 on volume of 2,945,646 shares. Over the past year the S&P 500 is up 22.16% while SRNE has fallen -44.06%. SRNE lost -$1.22 per share the over the last 12 months. Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App